Prism Medico & Pharmacy (BOM:512217) ROCE %: -3.18% (As of Mar. 2026)

What is Prism Medico & Pharmacy ROCE %?

Prism Medico & Pharmacy BOM:512217 53 ROCE % is -3.18% as of Mar. 2026. GuruFocus rates BOM:512217 with a GF Score™ of 53/100 and a GF Value™ of ₹27.39 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Prism Medico & Pharmacy's annualized ROCE % for the quarter that ended in Mar. 2026 was -3.18%.

Prism Medico & Pharmacy (BOM:512217) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Prism Medico & Pharmacy ROCE % Related Terms

Prism Medico & Pharmacy ROCE % Historical Data

* Premium members only.

The historical data trend for Prism Medico & Pharmacy's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Medico & Pharmacy ROCE % Chart

Prism Medico & Pharmacy Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

-3.91

-0.75

-0.95

-0.42

2.84

Prism Medico & Pharmacy Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															0.63	17.25	0.00	0.00	-3.18

53GF Score

Prism Medico & Pharmacy Ltd BOM:512217

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Prism Medico & Pharmacy ROCE % Calculation

Prism Medico & Pharmacy's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	4.329	/	( ( (155.645 - 4.717)	+	(156.111 - 1.999) )	/ 2 )
	=	4.329	/	( (150.928	+	154.112)	/ 2 )
	=	4.329	/	152.52
	=	2.84 %

Prism Medico & Pharmacy's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-4.904	/	( ( (0 - 0)	+	(156.111 - 1.999) )	/ 1 )
	=	-4.904	/	( ( 0	+	154.112 )	/ 1 )
	=	-4.904	/	154.112
	=	-3.18 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -3.18% mean?

Prism Medico & Pharmacy (BOM:512217) has a ROCE % of -3.18% as of Mar. 2026.

Is Prism Medico & Pharmacy's ROCE % too high?

Prism Medico & Pharmacy's current ROCE % is -3.18%. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Prism Medico & Pharmacy's ROCE % compare to ADM and BG?

Prism Medico & Pharmacy's ROCE % of -3.18% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Consumer Packaged Goods company?

The median ROCE % among Consumer Packaged Goods companies is 8.78, based on 1,933 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current ROCE % is -3.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Prism Medico & Pharmacy stock overvalued right now?

Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.39, compared to a current price of ₹28.80 — trading 5.1% above its estimated fair value. The current ROCE % is -3.18%. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current ROCE % is -3.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?

Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued. The current stock price of ₹28.80 is trading 5.1% above its estimated GF Value™ of ₹27.39. GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.

Key valuation signals for BOM:512217:

ROCE %: -3.18%
GF Value™: ₹27.39 vs. price of ₹28.80 (5.1% above fair value)
GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prism Medico & Pharmacy Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies BOM:543769 BOM:530805 NSE:SRPL BOM:519500 NSE:GAJANAND BOM:519506 BOM:538520 BOM:519574 BOM:544436 BOM:544011 ADM SZSE:002714 BG TSN SZSE:300498 OSL:MOWI OSL:SALM XKLS:2089 XPAR:LOUP SZSE:300972

Address C/o. Sunrise Enterprises, Suketi Road, Sirmaur District, Kala Amb, HP, IND, 173030

Website https://www.prismmedico.in

Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.

53GF Score

Get the complete analysis for BOM:512217

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.80

Price

₹27.39

GF Value

View BOM:512217 Analysis

See ROCE % data for all stocks →